Singapore markets closed

Grifols, S.A. (GRFS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.68+0.03 (+0.45%)
At close: 04:00PM EDT
6.68 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.65
Open6.58
Bid6.62 x 400
Ask6.71 x 400
Day's range6.50 - 6.70
52-week range5.30 - 12.15
Volume1,026,161
Avg. volume3,397,398
Market cap5.486B
Beta (5Y monthly)0.67
PE ratio (TTM)66.80
EPS (TTM)0.10
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date03 Jun 2021
1y target est15.71
  • Reuters

    Spain's supervisor CNMV finds no significant errors in Grifols accounts

    Beleaguered Spanish drugmaker Grifols will not be required to restate its accounts for the years 2021 and 2022, market supervisor CNMV said on Thursday, as its investigation found no significant errors in the amounts it had reported. CNMV also found "no evidence that the financial debt reported by Grifols does not correspond to reality," it said. Since early January, short-sheller Gotham City Research had released three reports repeatedly accusing Grifols of overstating earnings and understating debt in its financial accounts.

  • Reuters

    UPDATE 2-Europe's STOXX 600 logs weekly gains, US jobs data in focus

    Europe's main stock indices were flat on Friday, but notched strong gains over the week that saw record highs from German and French shares, while investors also analysed a U.S. jobs report for clues on the global monetary policy outlook. Technology lost 1.6% after BE Semiconductor slumped 16.1% on a media report that Joint Electron Device Engineering Council lowered certain chip standards which might delay investments into hybrid bonding technology.

  • Reuters

    Grifols' shares rise 16% after auditor's 2023 results opinion

    Shares of Spanish drugmaker Grifols rose more than 16% on Friday morning after it said auditor KPMG approved its 2023 results with an unqualified opinion, without modifying the profit and debt ratio previously reported. Grifols last week published its 2023 results, pending an audit, which analysts said contributed to the share price's tumbling along with doubts about its cash flow for 2024. Since early January, a report by short-seller fund Gotham City Research that questioned Grifols' accounting and debt ratio has cast doubts about the company's business and wiped off billions of euros in market value.